Table 2.
Detection of HDV for patients with HBV-related diseases
| Patient cohorts | Anti-HDV IgG | Anti-HDV IgM | RT-PCR | ddPCR | ||||||
| Number | Positive rate (%) | Number | Positive rate (%) | Number | HDV-positive rate in total (%) | RNA-positive rate in HDV infection (%) | Number | HDV-positive rate in total (%) | RNA-positive rate in HDV infection (%) | |
| Chronic hepatitis B (n = 182) | 2 | 1.1 | 0 | — | 0 | — | — | 0 | — | — |
| Liver cirrhosis (n = 182) | 6 | 3.3 | 2 | 1.1 | 1 | 0.55 | 16.67 | 2 | 1.1 | 33.33 |
| Liver failure (n = 182) | 13 | 7.1 | 4 | 2.2 | 2 | 1.1 | 15.4 | 4 | 2.2 | 30.77 |
| Hepatocellular carcinoma (n = 182) | 5 | 2.7 | 3 | 1.6 | 1 | 0.55 | 20 | 3 | 1.6 | 60 |
ddPCR, digital droplet PCR; HDV, hepatitis delta virus; Ig, immunoglobulin; RT-PCR, reverse-transcriptase PCR.